sr141716 has been researched along with cp 55244 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, AJ; Brown, J; Brown, S; Daniels, DA; Dowell, SJ; Haslam, CP; Kassim, M; Nichols, PL; Staton, PC; Terrell, VR; Wise, A | 1 |
| Abood, ME; Griffin, G; Martin, BR; Wray, EJ | 1 |
| Cartier, E; Edwards, JL; Howlett, AC; Shim, JY; Welsh, WJ | 1 |
3 other study(ies) available for sr141716 and cp 55244
| Article | Year |
|---|---|
Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.
Topics: Dose-Response Relationship, Drug; Glycine Plasma Membrane Transport Proteins; HEK293 Cells; Humans; Piperazines; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Saccharomyces cerevisiae; Yeasts | 2011 |
Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum.
Topics: Allosteric Regulation; Animals; Benzoxazines; Cerebellum; Male; Morpholines; Naphthalenes; Piperidines; Protein Binding; Pyrazoles; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 1999 |
Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.
Topics: Algorithms; Animals; Brain; Kinetics; Ligands; Models, Chemical; Models, Molecular; Naphthalenes; Piperidines; Protein Binding; Protein Conformation; Protons; Pyrazoles; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Software; Structure-Activity Relationship | 2002 |